GNFT Stock Summary and Trading Ideas (Genfit S.A. - American Depositary Shares | NASDAQ:GNFT)

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Genfit S.A. - American Depositary Shares trades on the NASDAQ stock market under the symbol GNFT.

As of May 13, 2024, GNFT stock price declined to $3.73 with 504 million shares trading.

GNFT has a market cap of $185.88 million. This is considered a Micro Cap stock.

In the last 3 years, GNFT stock traded as high as $6.38 and as low as $2.89.

The top ETF exchange traded funds that GNFT belongs to (by Net Assets): APIE.

GNFT has underperformed the market in the last year with a return of -12.4%, while the SPY ETF gained +27.9%. In the last 3 month period, GNFT fell short of the market, returning +1.6%, while SPY returned +4.3%. However, in the most recent 2 weeks GNFT has outperformed the stock market by returning +6.9%, while SPY returned +2.6%.

GNFT support price is $3.61 and resistance is $3.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNFT stock will trade within this expected range on the day.